Company / Assets per Share
Vanda Pharmaceuticals Inc. Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$8.39
FY2025
5-year range
$8.39 / $11.42
FY2021-FY2025
Trend
-26.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $11.42 to $8.39 over the past 2 years.
Based on SEC 10-K filings.
8.39 in FY2025 with a 5-year CAGR of -3.4%.
Declined from $11.42 to $8.39 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -9.6%
- 5-Year CAGR
- -3.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, assets per share decreased 26.5% year-over-year.
- Peak assets per share was recorded in FY2023.
- Lowest assets per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -3.96 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.39 | -26.5% |
| FY2024 | $11.41 | -0.1% |
| FY2023 | $11.42 | +0.6% |
| FY2022 | $11.35 | +4.8% |
| FY2021 | $10.82 | +8.6% |
| FY2020 | $9.96 | +8.1% |
| FY2019 | $9.22 | +24.7% |
| FY2018 | $7.39 | +58.3% |
| FY2017 | $4.67 | -5.0% |
| FY2016 | $4.91 | -4.3% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026